As with any medication, bio-identical hormone replacement therapy (BHRT) carries potential risks. However, it's equally important to consider the risks associated with not taking BHRT from perimenopause or menopause and beyond.
Think about this for a minute...The evidence-based research mentions that taking estrogen in midlife and beyond decreases your chances of:
-breast cancer by 25%-colon cancer by 9%-bone fracture by 50% and death due to a fracture from 25%-vaginal atrophy by 90%-and all-cause mortality by 50%. Can you think of a drug, currently existing that reduces all-cause mortality by 50%? Well estrogen does that for perimenopausal and menopausal women.
Generally, the risks of bio-identical hormones are minimal. While some research indicates a slightly increased risk for certain individuals when using synthetic hormones compared to bio-identical ones, the prevailing evidence suggests that failing to replace estradiol, progesterone, and testosterone in midlife and beyond often presents greater risks to heart, brain, bone, and vaginal health than the addition of bio-identical hormones.
Understanding your individual risks and benefits is crucial, as perimenopause and menopause are highly personal journeys. For most, taking bio-identical hormones in midlife and beyond not only relieve symptoms, but is disease preventative; it's about your future health.
We encourage you to explore our summarized evidence-based library and join the 24/7 Essend Community Discord chat, where you can connect with perimenopause/menopause experts and receive support throughout your journey.
To learn more, search "BHRT" on our platform.
